Related by context. Frequent words. (Click for all words.) 72 Shareholder Letter 69 FY# Guidance 69 Annual Meeting Date 69 Option Grants 67 Patient Enrollment 67 Share Repurchases 67 Regains Compliance 67 Shareholder Lawsuit 66 Preliminary Third Quarter 66 Previously Announced 66 Summarizes 65 Provides Guidance 65 3rd Quarter Results 65 Regains Compliance With 65 Guidance Quick Facts 65 Explore Strategic Alternatives 65 2nd Quarter Results 65 Inc Therapeutic Competitors 65 Record Second Quarter 65 FDA Accepts 65 Updates Shareholders 64 Issues Guidance 64 #.#/Share [002] 64 Forecast Quick Facts 64 Q3 Loss Narrows 64 Shareholder Vote 64 Shelf Registration Statement 64 Continued Listing 64 Updates Guidance 63 Q2 Loss Widens 63 Complete Merger 63 1st Quarter Results 63 Updates Status 63 Q1 Loss Narrows 63 Receives Positive 63 Q2 Loss Narrows 63 Declares Increased 63 -leukemias 63 Clinical Trial Results 63 Record Third Quarter 63 Files Annual Report 63 Drug Candidate 63 Shareholder Update 63 Announces Publication 62 Provides Updates 62 Vicor Technologies 62 Shareholder Approval 62 Patent Infringement Lawsuit 62 CFO Resigns 62 Reconfirms 62 Announces Initiation 62 Q3 Loss Widens 62 Mechel Announces 62 Releases Third Quarter 62 Record Fourth Quarter 62 Supplementary Data 62 Smallpox Vaccine 62 Sunesis Pharmaceuticals 62 Filing Deadline 62 Provides Preliminary 62 Completes Enrollment 61 Anthrax Vaccine 61 4Q Loss Widens 61 Risks Associated 61 Operational Results 61 Q1 Loss Widens 61 Goldfarb Branham Law Firm 61 Q4 Loss Narrows 61 Nine Month 61 Guides Q4 61 Private Placement Financing 61 Q4 Loss Widens 61 Shareholder Opinions 61 Patent Covering 61 Preliminary Fourth Quarter 61 EPIX Pharmaceuticals 61 Goodwill Impairment 61 AVANIR Pharmaceuticals 60 Director Shareholding 60 Positive Opinion 60 Reaffirms Guidance 60 Strategic Alternatives 60 Editorial Roundup Excerpts 60 Backs FY# EPS 60 REVIEW OF 60 Significant Increase 60 Statutory Basis 60 Lowers Guidance 60 Quarterly Activities 60 Guides Q2 60 Stockholders Approve Merger 60 Extends Tender Offer 60 Adroit Resources Inc. 60 Guides FY# 60 MedCom USA Inc. 60 Guides Q3 60 Stock Buyback 60 FINANCIAL CONDITION AND 60 Low Dose 60 Posts Wider Loss 60 Receives Notice